Recent advancements in the discovery of protein-protein interaction inhibitors of replication protein A

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• The DNA damage response (DDR) pathway is crucial for eukaryotic cell survival due to frequent DNA damage during the cell cycle.
• Replication protein A (RPA) is a key checkpoint protein initiating the DDR by binding to single-stranded DNA (ssDNA).

Purpose of the Study:

• To review the structure and function of RPA.
• To highlight recent advancements in discovering inhibitors of RPA-protein interactions for potential cancer drug development.

Main Methods:

• Literature review of RPA structure, function, and DDR.
• Summary of various methods used to explore RPA inhibitors.
• Analysis of protein-protein interactions (PPIs) involving RPA.

Main Results:

• RPA's critical role in initiating DDR and promoting cell survival is established.
• Various strategies are being employed to develop RPA inhibitors.
• Understanding RPA-PPIs is key to developing targeted cancer therapies.

Conclusions:

• RPA is a significant target for cancer drug discovery due to its role in DNA repair and cell survival.
• Inhibiting RPA-protein interactions holds promise for novel cancer therapeutics.
• Further research into RPA inhibitors could lead to effective cancer treatments.